Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
Schwarz Pharma (2006)
|
| gptkbp:ceo |
gptkb:Jean-Christophe_Tellier
|
| gptkbp:employees |
7,500 (2020)
|
| gptkbp:founded |
1928
|
| gptkbp:headquarters |
gptkb:Brussels,_Belgium
|
| https://www.w3.org/2000/01/rdf-schema#label |
UCB Pharma Ltd.
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:products |
gptkb:Briviact
gptkb:Cimzia gptkb:Neupro |
| gptkbp:region |
Worldwide
|
| gptkbp:revenue |
€5.1 billion (2020)
|
| gptkbp:specialization |
neurology
immunology |
| gptkbp:stock_exchange |
gptkb:Euronext_Brussels
|
| gptkbp:subsidiary |
UCBS. A.
|
| gptkbp:symbol |
gptkb:UCB
|
| gptkbp:website |
www.ucb.com
|
| gptkbp:bfsParent |
gptkb:UCB,_Inc.
|
| gptkbp:bfsLayer |
5
|